Back to results
US 8,703,467 B2Granted
Inactivation of a pathogen in a sample by a treatment with formalin and UV light
AssigneesBaxter International Inc., Baxter Healthcare S.A.
InventorsManfred Reiter, Wolfgang Mundt, Noel Barrett, Otfried Kistner
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for inactivating virus in a sample by treating a virus containing sample with an effective concentration of formalin and by treating the sample with an effective dose of UV light in a flow-through apparatus.
Claims20
A method for inactivating an enveloped virus contained in a sample for producing a vaccine, comprising the steps of
- (i) treating the sample with an effective concentration of formalin, and
- (ii) subjecting the sample to an effective dose of UV light in a flow-through apparatus,
- wherein step (i) is performed prior to step (ii) or vice versa, and
- wherein the enveloped virus is wholly inactivated, thereby being suitable for use in producing the vaccine.
1 more element
Dependencies are inferred from the claim text.